We are live on ! Find out more

1,453 hedge funds and large institutions have $98.5B invested in Amgen in 2015 Q4 according to their latest regulatory filings, with 166 funds opening new positions, 562 increasing their positions, 510 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more first-time investments, than exits

New positions opened: 166 | Existing positions closed: 74

37% more funds holding in top 10

Funds holding in top 10: 81111 (+30)

17% more capital invested

Capital invested by funds: $83.9B → $98.5B (+$14.6B)

10% more repeat investments, than reductions

Existing positions increased: 562 | Existing positions reduced: 510

5% more funds holding

Funds holding: 1,3801,453 (+73)

4% more call options, than puts

Call options by funds: $945M | Put options by funds: $907M

Holders
1,453
Holders Change
+73
Holders Change %
+5.29%
% of All Funds
38.12%
Holding in Top 10
111
Holding in Top 10 Change
+30
Holding in Top 10 Change %
+37.04%
% of All Funds
2.91%
New
166
Increased
562
Reduced
510
Closed
74
Calls
$945M
Puts
$907M
Net Calls
+$37.6M
Net Calls Change
-$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
GE
26
General Electric
Ohio
$551M -$9M -57,261 -2%
Schroder Investment Management Group
27
Schroder Investment Management Group
United Kingdom
$536M -$38.3M -243,753 -7%
UBS AM
28
UBS AM
Illinois
$536M -$76.3M -485,621 -13%
Charles Schwab
29
Charles Schwab
California
$527M +$1.74M +11,041 +0.3%
Legal & General Group
30
Legal & General Group
United Kingdom
$524M +$14.8M +94,032 +3%
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$510M -$11.3M -72,156 -2%
State Farm Mutual Automobile Insurance
32
State Farm Mutual Automobile Insurance
Illinois
$506M
LSV Asset Management
33
LSV Asset Management
Illinois
$480M -$7.29M -46,382 -2%
O
34
OrbiMed
New York
$474M -$14.5M -92,000 -3%
Goldman Sachs
35
Goldman Sachs
New York
$470M -$42.8M -272,495 -9%
Allianz Asset Management
36
Allianz Asset Management
Germany
$468M +$13.9M +88,447 +3%
WRF
37
Waddell & Reed Financial
Kansas
$456M -$87.1M -554,286 -16%
Capital International Investors
38
Capital International Investors
California
$435M
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$430M +$52.2M +332,329 +14%
Loomis, Sayles & Company
40
Loomis, Sayles & Company
Massachusetts
$418M +$17.9M +113,684 +5%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$410M +$173M +1,100,809 +77%
BIM
42
BlackRock Investment Management
Delaware
$405M +$13.8M +87,862 +4%
LTI
43
Laffer Tengler Investments
Tennessee
$400M
PNC Financial Services Group
44
PNC Financial Services Group
Pennsylvania
$396M +$2.8M +17,844 +0.7%
BlackRock
45
BlackRock
New York
$390M +$585K +3,723 +0.2%
VOYA Investment Management
46
VOYA Investment Management
Georgia
$361M +$67.7M +430,656 +24%
JP Morgan Chase
47
JP Morgan Chase
New York
$357M +$47.7M +303,485 +16%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$356M -$10.7M -68,250 -3%
Sumitomo Mitsui Trust Group
49
Sumitomo Mitsui Trust Group
Japan
$354M +$6.33M +40,291 +2%
Prudential Financial
50
Prudential Financial
New Jersey
$345M +$16.9M +107,390 +5%

AMGN Hedge Fund Activity: Q4 2015 in Review

1,453 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2015, worth a combined $98.5B — up 17% from $83.9B a quarter earlier.

Buyers outnumbered sellers: 166 funds opened new AMGN positions and 74 closed out — a net gain of 92 holders — while 562 added to existing stakes and 510 trimmed.

The largest buyer was Wells Fargo, adding an estimated $321M. The largest seller was Renaissance Technologies, cutting an estimated $223M.

  • 1,453 institutional investors held Amgen (AMGN) as of Q4 2015, up from 1,380 in Q3 2015.
  • Funds reported $98.5B of Amgen stock for Q4 2015, up 17% quarter-over-quarter.
  • 166 funds opened new Amgen positions in Q4 2015 and 74 closed out, a net change of +92 holders.
  • The largest Amgen buyer in Q4 2015 was Wells Fargo, an estimated $321M added.
  • The largest Amgen seller in Q4 2015 was Renaissance Technologies, an estimated $223M sold.

Based on aggregated 13F filings for Q4 2015.